News Related to CurateQ Biologics

Related coverage linked through entity extraction aliases.

Aurobindo Pharma Subsidiaries Secure FDA, Health Canada, and EU Biosimilar Approvals and Partnerships

May 01, 2026

Aurobindo Pharma's subsidiaries secured Health Canada approval for bevacizumab biosimilar Bevqolva, an EU distribution deal with STADA for two EMA-approved biosimilars, and US FDA approval for ADQUEY ointment for atopic dermatitis.

Zydus Lifesciences Launches India's First Indigenous Aflibercept Biosimilar ANYRA

Mar 13, 2026

Zydus Lifesciences launched ANYRA, India's first indigenously developed aflibercept biosimilar, on February 19, 2026, following an agreement with Regeneron Pharmaceuticals and Bayer for multiple ophthalmic indications.